Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification

Sponsor
Afyon Kocatepe University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03321253
Collaborator
(none)
38
1
6.8

Study Details

Study Description

Brief Summary

It has been hypothesized that potential effects of laser Nd: YAG laser posterior capsulotomy may affect macular pigment as well as choroidal thickness, macular thickness and anterior chamber parameters, so it was aimed to investigate possible effects of Nd: YAG laser posterior capsulotomy on macular pigment optical density, choroidal thickness, macular thickness and anterior chamber parameters in cases with posterior capsule opacification in this study.

Condition or Disease Intervention/Treatment Phase
  • Device: Nd: YAG laser posterior capsulotomy
N/A

Detailed Description

This clinical trial was conducted following the principles of the Declaration of Helsinki. The local authorized clinical trials ethics committee approved the protocol and consent forms (Afyon Kocatepe University Clinical Trials Ethics Committee, 2011-KAEK-2 2017/172). Between 2015 and 2016, 38 pseudophakic participants were enrolled in this study. After providing information to patients about the disease and treatment, patients predicted to show adherence to treatment, were enrolled in the study.

Detailed ophthalmological examinations of all subjects were performed prior to Nd: YAG laser posterior capsulotomy intervention. Anterior chamber parameters of cases with PCO were measured Measurements of IOP, anterior chamber parameters, visual acuity, Slit-lamp, gonioscopy and fundus examinations, and measurements of central macular thickness (CMT), choroidal thicknesses (CTs), and MPOD were performed after maximal pupil dilatation.

Proposed procedure, including risks, benefits, and alternatives were discussed with all subjects, and all participants signed of informed consent form.

Choroidal thicknesses were recorded as subfoveal CT (SCT), nasal CT (NCT) and temporal CT (TCT).

MPOD measurements were subsequently made by using luminance differential thresholds test. After measurements a refractive surgery specialist carried out Nd: YAG laser posterior capsulotomy interventions to patients who were decided to applying Nd:YAG laser capsulotomy.

All examinations and measurements were repeated and recorded at 1st week, 1st and 2nd month.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Intervention Model:
Sequential Assignment
Intervention Model Description:
sequential self-controlled clinical trialsequential self-controlled clinical trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Changes of Macular Pigment Optical Density and Parameters After Nd: YAG Laser Posterior Capsulotomy in Cases With Posterior Capsule Opacification
Actual Study Start Date :
Oct 23, 2015
Actual Primary Completion Date :
Apr 12, 2016
Actual Study Completion Date :
May 16, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nd: YAG laser posterior capsulotomy

Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months

Device: Nd: YAG laser posterior capsulotomy
Nd: YAG laser posterior capsulotomy
Other Names:
  • Tango Laserex
  • Outcome Measures

    Primary Outcome Measures

    1. Changes of Foveal and Pericentral Pigment Optical Density (Log Unit) From Baseline at 2 Months [2 months]

      Foveal and pericentral pigment optical density was measured by using color perimetry technique and recorded as log unit before Nd: YAG laser posterior capsulotomy, at 1 week, 1 month and 2 months

    2. Changes of Subfoveal, Temporal and Nasal Choroidal Thicknesses (Micrometer) From Baseline at 2 Months [2 months]

      Subfoveal, temporal and nasal choroidal thicknesses were measured by using enhanced-deep imaging optical coherence tomography and recorded as micrometer before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month

    3. Changes of Anterior Chamber Depth (Millimeter) From Baseline at 2 Months [2 months]

      Anterior chamber depth was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month

    4. Changes of Iridocorneal Angle From Baseline at 2 Months [2 months]

      Iridocorneal angle was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and 2-month

    Secondary Outcome Measures

    1. Changes of Central Macular Thicknesses (Micrometer) From Baseline at 2 Months [2 Months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Best-corrected visual acuity (BCVA) logMAR <0.3

    • Duration at least 2 years after cataract surgery

    • Between the ages of 45 and 65 years (45≤age≤65)

    Exclusion Criteria:
    • Corneal scarring, diffuse posterior PCO or intravitreal hemorrhage that prevents appearance of the fundus

    • Occluded angle by gonioscopy (grade 0, narrow angle, grade I, grade II)

    • Presence of macular or peripheral retinal pathologies or choroidopathy

    • High risk for RD

    • Presence of macular edema in the macular area

    • Detection of macular fluid or edema in OCT

    • Active intraocular inflammation

    • Previous laser PRP, Nd: YAG laser posterior capsulotomy, laser iridotomy or selective laser trabeculoplasty interventions

    • Previous iridectomy, glaucoma or vitreoretinal surgery

    • Glass intraocular lens

    • Spherical refractive error ≥ ±6.00 D or cylinder refractive error ≥ ±3.00 D

    • Inadequate stability of the eye

    • Systemic diseases that may affect the choroidal blood flow such as cardiological diseases

    • Current use of carotenoid supplementation

    • Changing eating habits

    • Gastrointestinal diseases that could cause disturbance of dietary absorption

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Afyon Kocatepe University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Bunyamin Kutluksaman, Principal Investigator, Afyon Kocatepe University Hospital
    ClinicalTrials.gov Identifier:
    NCT03321253
    Other Study ID Numbers:
    • 2011-KAEK-2 2017/172
    First Posted:
    Oct 25, 2017
    Last Update Posted:
    Aug 7, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Bunyamin Kutluksaman, Principal Investigator, Afyon Kocatepe University Hospital
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Period Title: Overall Study
    STARTED 38
    COMPLETED 38
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Overall Participants 38
    Age (Count of Participants)
    <=18 years
    0
    0%
    Between 18 and 65 years
    38
    100%
    >=65 years
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    55.37
    (4.45)
    Sex: Female, Male (Count of Participants)
    Female
    19
    50%
    Male
    19
    50%
    Region of Enrollment (participants) [Number]
    Turkey
    38
    100%

    Outcome Measures

    1. Primary Outcome
    Title Changes of Foveal and Pericentral Pigment Optical Density (Log Unit) From Baseline at 2 Months
    Description Foveal and pericentral pigment optical density was measured by using color perimetry technique and recorded as log unit before Nd: YAG laser posterior capsulotomy, at 1 week, 1 month and 2 months
    Time Frame 2 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Measure Participants 38
    MPOD fovea at baseline
    0.55
    (0.07)
    MPOD fovea at 1-week
    0.52
    (0.08)
    MPOD fovea at 1-month
    0.51
    (0.09)
    MPOD fovea at 2-month
    0.5
    (0.09)
    MPOD pericentral at baseline
    0.33
    (0.05)
    MPOD pericentral at 1-week
    0.31
    (0.05)
    MPOD pericentral at 1-month
    0.3
    (0.06)
    MPOD pericentral at 2-month
    0.29
    (0.06)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection Nd: YAG Laser Posterior Capsulotomy
    Comments
    Type of Statistical Test Other
    Comments
    Statistical Test of Hypothesis p-Value <0.01
    Comments
    Method ANOVA
    Comments
    2. Primary Outcome
    Title Changes of Subfoveal, Temporal and Nasal Choroidal Thicknesses (Micrometer) From Baseline at 2 Months
    Description Subfoveal, temporal and nasal choroidal thicknesses were measured by using enhanced-deep imaging optical coherence tomography and recorded as micrometer before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month
    Time Frame 2 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Measure Participants 38
    Subfoveal choroidal thickness baseline
    276.46
    (19.36)
    Subfoveal choroidal thickness at 1-week
    276.54
    (19.45)
    Subfoveal choroidal thickness at 1-month
    276.86
    (19.42)
    Subfoveal choroidal thickness at 2-month
    276.76
    (19.36)
    Temporal choroidal thickness at baseline
    275.04
    (20.59)
    Temporal choroidal thickness at 1-week
    275.02
    (20.67)
    Temporal choroidal thickness at 1-month
    275.23
    (20.64)
    Temporal choroidal thickness at 2-month
    275.03
    (20.56)
    Nasal choroidal thickness at baseline
    271.16
    (19.64)
    Nasal choroidal thickness at 1-week
    271.33
    (19.74)
    Nasal choroidal thickness at 1-month
    271.75
    (19.71)
    Nasal choroidal thickness at 2-month
    271.74
    (19.62)
    3. Primary Outcome
    Title Changes of Anterior Chamber Depth (Millimeter) From Baseline at 2 Months
    Description Anterior chamber depth was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and at 2-month
    Time Frame 2 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Measure Participants 38
    ACD at baseline
    3.7
    (0.06)
    ACD at 1-week
    3.73
    (0.06)
    ACD at 1-month
    3.74
    (0.06)
    ACD at 2-month
    3.75
    (0.07)
    4. Primary Outcome
    Title Changes of Iridocorneal Angle From Baseline at 2 Months
    Description Iridocorneal angle was measured by using anterior segment module optical coherence tomography and recorded as millimeter before Nd: YAG laser posterior capsulotomy, at 1 week, at 1-month and 2-month
    Time Frame 2 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Measure Participants 38
    ICA at baseline
    36.59
    (1.22)
    ICA at 1-week
    39.92
    (2.1)
    ICA at 1-month
    41.62
    (3.39)
    ICA at 2-month
    42.04
    (4.18)
    5. Secondary Outcome
    Title Changes of Central Macular Thicknesses (Micrometer) From Baseline at 2 Months
    Description
    Time Frame 2 Months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    Measure Participants 38
    Central Macular Thickness Baseline
    235.79
    (13.48)
    Central Macular Thickness 1-week
    243.08
    (14.32)
    Central Macular Thickness 1-month
    244.76
    (14.82)
    Central Macular Thickness 2-month
    245.5
    (15.24)

    Adverse Events

    Time Frame 1 year
    Adverse Event Reporting Description All-Cause Mortality, and Serious-Adverse Events were not monitored
    Arm/Group Title Nd: YAG Laser Posterior Capsulotomy
    Arm/Group Description Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week, 1 month and 2 months Nd: YAG laser posterior capsulotomy: Nd: YAG laser posterior capsulotomy
    All Cause Mortality
    Nd: YAG Laser Posterior Capsulotomy
    Affected / at Risk (%) # Events
    Total 0/0 (NaN)
    Serious Adverse Events
    Nd: YAG Laser Posterior Capsulotomy
    Affected / at Risk (%) # Events
    Total 0/0 (NaN)
    Other (Not Including Serious) Adverse Events
    Nd: YAG Laser Posterior Capsulotomy
    Affected / at Risk (%) # Events
    Total 0/38 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Bunyamin Kutluksaman
    Organization Necip Fazil City Hospital
    Phone 903442282800
    Email bkutluksaman@gmail.com
    Responsible Party:
    Bunyamin Kutluksaman, Principal Investigator, Afyon Kocatepe University Hospital
    ClinicalTrials.gov Identifier:
    NCT03321253
    Other Study ID Numbers:
    • 2011-KAEK-2 2017/172
    First Posted:
    Oct 25, 2017
    Last Update Posted:
    Aug 7, 2019
    Last Verified:
    Jul 1, 2019